Mortality News and Research

RSS

Postcode lottery of life: ONS data reveals shocking life expectancy gaps across UK

Where you live must not determine how long you live. Regular testing is needed to end the postcode health lottery, says a leading expert.

5 Feb 2024

COVID-19 recovery disparities uncovered among racial and ethnic groups

Study reveals ethnic and racial disparities in health outcomes post-COVID-19 infection, with Hispanic and racial minority groups reporting poorer health status and increased work absence compared to their non-Hispanic and White counterparts.

4 Feb 2024

XBB.1.5 updated COVID vaccine booster offers 54% increased protection against symptomatic infection

Early estimates show the 2023-24 updated monovalent XBB.1.5 COVID-19 vaccine offers significant protection against symptomatic infection, with effectiveness varying by age and time since vaccination.

4 Feb 2024

Exercise shapes our gut health, study finds

Accelerometer-based study reveals physical activity levels significantly influence gut microbiota composition, linking moderate and vigorous exercise to beneficial microbial diversity and function.

3 Feb 2024

Gut health linked to Alzheimer's progression, study suggests diet as potential therapy

Study reviews the intricate relationship between diet, gut microbiome diversity, and Alzheimer’s disease progression, suggesting gut health could play a key role in managing the disease.

3 Feb 2024

Has a decade of maternal pertussis vaccination reduced its effectiveness?

Research indicates maternal immunization against pertussis remains crucial for newborn protection despite concerns of reduced vaccine effectiveness over time, underscoring its vital role in preventing infant mortality.

3 Feb 2024

CRISPR-Cas9 gene-editing tool repairs defective T cells to treat rare hereditary disease

Some hereditary genetic defects cause an exaggerated immune response that can be fatal. Using the CRISPR-Cas9 gene-editing tool, such defects can be corrected, thus normalizing the immune response, as researchers led by Klaus Rajewsky from the Max Delbrück Center now report in "Science Immunology."

2 Feb 2024

Evaluating effectiveness of various COVID-19 vaccine doses after primary vaccination

First boosters, second boosters, monovalent, bivalent. Just like the SARS-CoV-2 virus strain, the vaccines to combat the virus are always changing—and perhaps confusing.

2 Feb 2024

Comparing perioperative differences: Sleeve gastrectomy vs. Roux-en-Y gastric bypass

Study compares laparoscopic sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) in obese patients, finding both procedures have low, comparable perioperative risks and complications, challenging the criteria for selecting between the two surgeries.

1 Feb 2024

High maternal cortisol levels linked to unexpected birth problems

A snippet of hair can reveal a pregnant person's stress level and may one day help warn of unexpected birth problems, a study indicates.

1 Feb 2024

Cancer risk factors and barriers to cancer prevention services among people experiencing homelessness

While people experiencing homelessness are more exposed to cancer-associated risk factors, there is a lack of awareness and structures for targeted cancer prevention.

1 Feb 2024

Smartphone-based mall walking program could boost daily step count, study suggests

Researchers from Japan evaluated the effectiveness of smartphone-based programs that conduct mall walking in increasing the daily step count, especially after the COVID-19 pandemic.

1 Feb 2024

Circulatory cholesterol levels are inversely linked to mortality of patients with sepsis and critical illness

The association between biomarkers of cholesterol homeostasis and mortality in critically ill patients.

1 Feb 2024

Berry consumption shown to lower stress-related disease risk in US adults

The association between berry consumption and physiological dysregulation from stress responses.

1 Feb 2024

Mechanically ventilated patients in intermediate care units of rural hospitals have higher death rates

A new National Institutes of Health-supported study finds that patients receiving ventilator life support in the intermediate care units – a potentially less costly alternative for people not sick enough for the intensive care units (ICUs) but too ill for the general ward – of rural hospitals had significantly higher death rates than patients in the same type of unit at urban hospitals.

31 Jan 2024

Machine learning could personalize diuretic treatment for patients with acute decompensated heart failure

A recent study co-authored by Dr. Matthew Segar, a third-year cardiovascular disease fellow at The Texas Heart Institute and led by his research and residency mentor, University of Texas Southwestern Medical Center's Dr. Ambarish Pandey, utilized a machine learning-based approach to identify, understand, and predict diuretic responsiveness in patients with acute decompensated heart failure (ADHF).

31 Jan 2024

Resistance training can help lower risk factors for cardiovascular disease

A recent scientific statement from the American Heart Association suggests that resistance training is at least as safe as aerobic exercise for those with heart disease and other health conditions, and for most people can provide similar or additive benefits in lowering risk factors for cardiovascular disease.

31 Jan 2024

Are younger women experiencing a higher incidence of breast cancer?

Researchers evaluated the incidence of breast cancer among young women between the ages of 20 and 49 years. They assessed the incidence according to age at diagnosis, tumor stage, estrogen and progesterone hormone receptor status, and race and ethnicity.

31 Jan 2024

Enterprise Therapeutics closes £26 million ($33.1 million) Series B follow-on financing

Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of patients suffering from respiratory disease, today announced that it has closed a £26 million ($33.1 million USD) Series B follow-on financing round, led by Panakes Partners.

From Enterprise Therapeutics Ltd 31 Jan 2024

Understanding the interplay between gut microbiota and vascular dysfunction

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Vascular diseases, including atherosclerosis, aneurysms, and vascular calcification, are a leading cause of morbidity and mortality worldwide.

30 Jan 2024

Mortality News and Research

Postcode lottery of life: ONS data reveals shocking life expectancy gaps across UK

COVID-19 recovery disparities uncovered among racial and ethnic groups

XBB.1.5 updated COVID vaccine booster offers 54% increased protection against symptomatic infection

Exercise shapes our gut health, study finds

Gut health linked to Alzheimer's progression, study suggests diet as potential therapy

Has a decade of maternal pertussis vaccination reduced its effectiveness?

CRISPR-Cas9 gene-editing tool repairs defective T cells to treat rare hereditary disease

Evaluating effectiveness of various COVID-19 vaccine doses after primary vaccination

Comparing perioperative differences: Sleeve gastrectomy vs. Roux-en-Y gastric bypass

High maternal cortisol levels linked to unexpected birth problems

Cancer risk factors and barriers to cancer prevention services among people experiencing homelessness

Smartphone-based mall walking program could boost daily step count, study suggests

Circulatory cholesterol levels are inversely linked to mortality of patients with sepsis and critical illness

Berry consumption shown to lower stress-related disease risk in US adults

Mechanically ventilated patients in intermediate care units of rural hospitals have higher death rates

Machine learning could personalize diuretic treatment for patients with acute decompensated heart failure

Resistance training can help lower risk factors for cardiovascular disease

Are younger women experiencing a higher incidence of breast cancer?

Enterprise Therapeutics closes £26 million ($33.1 million) Series B follow-on financing

Understanding the interplay between gut microbiota and vascular dysfunction

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News